VIMNCT07317921
Validating IAAO for Muscle Outcomes
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 9 words Show 5 more changesShow less
- Primary endpoints: details revised at 4 of 4 entries
- Enrollment closed, study ongoing
- Study completion pushed from May 20, 2026 to Dec 20, 2026
- Primary completion date changed from estimate of Mar 20, 2026 to Apr 17, 2026
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Phenylalanine excretion (umol/kg/h)
Timeframe: 6.5 hours
Phenylalanine oxidation (umol/kg/h)
Timeframe: 6.5 hours
Myofibrillar protein synthesis (%/hr)
Timeframe: 6.5 hours
Sarcoplasmic protein synthesis (%/hr)
Timeframe: 6.5 hours
Arms and interventions
Protein + Stable Isotope Tracer BeverageExperimental
Participants will consume 12 half-hourly (6 hours) isoenergetic, isonitrogenous beverages containing 0.9g/kg fat-free mass/day protein. Drinks will be enriched with stable isotopes \[2H5\]Phenylalanine and \[1-13C\]Phenylalanine, which will respectively allow for determination of muscle protein synthesis and whole-body protein synthesis over the subsequent 6 hours of feeding.
Dietary supplements: Protein + Stable Isotope Tracer Beverage
Sites
1 site in 1 country
- Kinesiology & Physical EducationToronto, Ontario, Canada